Children born following VBAC and children born with ERCS had a similar risk of having a record of any SENs or a specific type of SEN
VBAC children: 19.24%
ERCS children: 17.63%
Adjusted risk ratio 1.04 (95% CI, 0.99 to 1.09)
There was little evidence that planned VBAC with or without labor induction was associated with a child’s risk of having a record of any SENs, compared to ERCS
With labor induction
aRR 1.09 (95% CI, 1.01 to 1.17)
Without labor induction
aRR 1.03 (95% CI, 0.98 to 1.08)
There was an increased risk of sensory impairment with planned VBAC with labor induction, compared with ERCS
VBAC with induction: 1.18%
Risk difference 0.4%
Adjusted odds ratio (OR) 1.60 (95% CI, 1.09 to 2.34)
Absolute risk difference: 0.4%
In-labor non-elective repeat cesarean was associated with reduced risk of language or speech disorder vs ERCS
Adjusted OR 0.76 (95% CI, 0.63–0.92)
Absolute risk difference: 0.99%
VBAC vs planned cesarean did not impact risk for special education needs in childhood
The small increased risk for sensory impairment with VBAC with labor induction and reduced risk for language or speech disorder with in-labor non-elective repeat caesarean may likely be the result of multiple comparisons or residual confounding
The authors state
To our knowledge, our study is the first to have examined the effect of labour induction after previous caesarean on child neurodevelopmental outcomes
There is little evidence planned mode of birth after previous caesarean section is associated with special educational needs in childhood
OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Jointly provided by
NOT ENOUGH CME HOURS
It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan